Heat-activated liposome targeting to streptavidin-coated surfaces

Biochimica Et Biophysica Acta
Yujia JingSofia Svedhem

Abstract

There is a great need of improved anticancer drugs and corresponding drug carriers. In particular, liposomal drug carriers with heat-activated release and targeting functions are being developed for combined hyperthermia and chemotherapy treatments of tumors. The aim of this study is to demonstrate the heat-activation of liposome targeting to biotinylated surfaces, in model experiments where streptavidin is used as a pretargeting protein. The design of the heat-activated liposomes is based on liposomes assembled in an asymmetric structure and with a defined phase transition temperature. Asymmetry between the inside and the outside of the liposome membrane was generated through the enzymatic action of phospholipase D, where lipid head groups in the outer membrane leaflet, i.e. exposed to the enzyme, were hydrolyzed. The enzymatically treated and purified liposomes did not bind to streptavidin-modified surfaces. When activation heat was applied, starting from 22°C, binding of the liposomes occurred once the temperature approached 33±0.5°C. Moreover, it was observed that the asymmetric structure remained stable for at least 2 weeks. These results show the potential of asymmetric liposomes for the targeted binding to cell membranes...Continue Reading

References

Jun 6, 2000·Advanced Drug Delivery Reviews·M Willis, E Forssen
May 18, 2001·Journal of Pharmaceutical Sciences·T Lian, R J Ho
Sep 3, 2002·Advanced Drug Delivery Reviews·Ashutosh ChilkotiDrazen Raucher
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lars H LindnerMarc Dellian
Jul 9, 2004·Journal of the American Chemical Society·Jin Liu, John C Conboy
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Sep 7, 2005·Cellular and Molecular Life Sciences : CMLS·G M Jenkins, M A Frohman
Dec 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M GoldenbergJean-François Chatal
Apr 6, 2006·Langmuir : the ACS Journal of Surfaces and Colloids·Ralf P RichterAlain R Brisson
Apr 29, 2010·Pharmaceutical Research·Gerben A KoningTimo L M ten Hagen
May 27, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Hanna P Wacklin
Sep 21, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Yuri GerelliGiovanna Fragneto
Dec 18, 2013·Journal of Pharmaceutical Sciences·John C KraftRodney J Y Ho

❮ Previous
Next ❯

Citations

Jan 13, 2018·Chemistry : a European Journal·Jinchao LouMichael D Best

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.